5 results match your criteria: "Lord Buddha Koshi Pharmacy College[Affiliation]"
Chem Biodivers
October 2024
Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, 51452, Saudi Arabia.
Hygrophila auriculata (K. Schum) Heine is known to treat various common aliment e. g.
View Article and Find Full Text PDFPak J Pharm Sci
September 2023
Department of Pharmacy Practice, College of Pharmacy, Shaqra University, Aldawadmi, Kingdom of Saudi Arabia.
Ficus religiosa L., a member of the Moraceae family, is a medicinal plant having a number of pharmacological properties. The anti-inflammatory and analgesic actions of an ethanolic extract of F.
View Article and Find Full Text PDFPlants (Basel)
September 2022
Lord Buddha Koshi Pharmacy College, Baijanathpur, NH 107, Saharsa 852201, Bihar, India.
(Malvaceae), more often referred to as Peeli booti, Kanghi, and Kakhi, is a perennial shrub found in many countries of Asia. Traditionally, this plant is used as a diuretic to treat inflammation, discomfort, urethral infections, and gout. Inflammation and pain are key topics of interest for researchers throughout the globe, since they are linked to almost every illness that could affect humans or animals.
View Article and Find Full Text PDFIran J Basic Med Sci
August 2022
Department of Pharmacology, School of Pharmaceutical Education and Research, (SPER) Jamia Hamdard, Delhi-110062, India.
Objectives: CB1 antagonism arbitrates a dormant shape to the endocannabinoid system that alleviates diverse pathological incidents of diabesity. The present study pursued the synthesis and evaluation of thiazolidine derivative (BAC) having pleiotropic action on CB1R, with or without AM251 (selective antagonist of the CB1 receptor) against high-fat diet (HFD) induced diabesity in C57BL/6 mice.
Materials And Methods: A molecular docking study for CB1 antagonistic potential was conducted by Maestro 11.
Evid Based Complement Alternat Med
July 2022
Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.
Cirsilineol has been reported to exhibit anticancer effects against several human cancer cell lines. The present study was designed to evaluate the anticancer effects of cirsilineol against the human DU-145 prostate cancer cells. The results showed that cirsilineol suppressed the proliferation of DU-145 cancer cells in a dose-dependent manner with minimal cytotoxic effects against the normal cells.
View Article and Find Full Text PDF